Skip to main content
TXG logo
TXG
(NASDAQ)
10x Genomics, Inc.
$22.33-- (--)
Loading... - Market loading

10x Genomics (TXG) Company Profile

Complete business overview, executive team, trading details, and corporate information.

10x Genomics, Inc.
TXGNASDAQHealthcareHealth Information Services

About 10x Genomics

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3’ gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Company Information

CEOSerge Saxonov
Founded2012
IPO DateSeptember 12, 2019
Employees1,178
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock
Share ClassClass A Shares

Contact Information

Phone925 401 7300
Address
6230 Stoneridge Mall Road Pleasanton, California 94588-3260 United States

Corporate Identifiers

CIK0001770787
CUSIP88025U109
ISINUS88025U1097
EIN45-5614458
SIC3826

Leadership Team & Key Executives

Dr. Serge Saxonov Ph.D.
Co-Founder, Chief Executive Officer and Director
Dr. Benjamin J. Hindson Ph.D.
Co-Founder, President, Chief Scientific Officer and Director
Adam S. Taich
Chief Financial Officer, Treasurer, Principal Financial Officer and Principal Accounting Officer
Jim Goodrich
Chief of Global Operations
Michael Schnall-Levin Ph.D.
Founding Scientist and Chief Technology Officer
Cassie Corneau
Manager of Investor Relations and Strategic Finance
Dr. Randy Wu
General Counsel and Secretary
Mennah Moustafa
Chief Commercial Officer
Jens Durruthy
Associate Director of Product Management